Bladder tissue engineering: Tissue regeneration and neovascularization of HA-VEGF-incorporated bladder acellular constructs in mouse and porcine animal models

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 4, 2010, Pages 1205-1215

  Loai, Yasir ^a   Yeger, Herman ^a   Coz, Cyrielle ^a   Antoon, Roula ^a   Islam, Syed S ^a   Moore, Katherine ^b   Farhat, Walid A ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acellular matrix (ACM); Angiogenesis; Tissue engineering; Urinary bladder; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; BLADDER TISSUE ENGINEERING; FACTOR VIII; HYALURONIC ACIDS; IMMUNOSTAINING; IN-SITU; IN-VIVO; MATRIX; MICROVASCULAR; MOUSE MODELS; NEOVASCULARIZATION; PORCINE MODELS; RECELLULARIZATION; REGENERATIVE CAPACITY; SMOOTH MUSCLE CELLS; TISSUE REGENERATION; URINARY BLADDER; UROTHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

GRAFTS; MODELS; ORGANIC ACIDS; PEPTIDES; SELF ASSEMBLY; TISSUE;

TISSUE ENGINEERING;

ALPHA SMOOTH MUSCLE ACTIN; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; COLLAGEN; HYALURONIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; EXPERIMENTAL PIG; FIBROSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PERITONEUM; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; TISSUE REGENERATION; UROTHELIUM; VASCULARIZATION;

ACTINS; ANIMALS; ANTIGENS, CD31; COLLAGEN; FACTOR VIII; FIBROSIS; GUIDED TISSUE REGENERATION; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MODELS, ANIMAL; MUSCLES; NEOVASCULARIZATION, PHYSIOLOGIC; SUS SCROFA; TISSUE ENGINEERING; TISSUE SCAFFOLDS; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956495006     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32777     Document Type: Article

References (45)

1. Filgueiras MF, Lima EM, Sanchez TM, Goulart EM, Menezes AC, Pires CR. Bladder dysfunction: Diagnosis with dynamic US. Radiology 2003;227:340-344.
2. Brown AL, Farhat W, Merguerian PA, Wilson GJ, Khoury AE, Woodhouse KA. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 2002;23:2179-2190. (Pubitemid 34226578)
3. Cartwright LM, Shou Z, Yeger H, Farhat WA. Porcine bladder acellular matrix porosity: Impact of hyaluronic acid and lyophilization. J Biomed Mater Res A 2006;77:180-184.
4. Farhat W, Chen J, Erdeljan P, Shemtov O, Courtman D, Khoury A, Yeger H. Porosity of porcine bladder acellular matrix: Impact of ACM thickness. J Biomed Mater Res A 2003;67:970-974.
5. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-580.
6. Reddy PP, Barrieras DJ, Wilson G, Bagli DJ, McLorie GA, Khoury AE, Merguerian PA. Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 2000;164(3 Part 2):936-941.
7. Cartwright L, Farhat WA, Sherman C, Chen J, Babyn P, Yeger H, Cheng HL. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: Pilot study. J Biomed Mater Res A 2006;77:390-395. (Pubitemid 47233541)
8. Robinson KA, Li J, Mathison M, Redkar A, Cui J, Chronos NA, Matheny RG, Badylak SF. Extracellular matrix scaffold for cardiac repair. Circulation 2005;112(9 Suppl):I135-I143.
9. Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol 2000;18:2-9.
10. McDougal WS. Metabolic complications of urinary intestinal diversion. J Urol 1992;147:1199-1208.
11. Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med 2002;23:463-483.
12. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002;277:41046-41059.
13. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 1999;47:152-169. (Pubitemid 29409734)
14. Collier JH, Camp JP, Hudson TW, Schmidt CE. Synthesis and characterization of polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications. J Biomed Mater Res 2000;50:574-584.
15. Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J Control Release 2000;69:169-184.
16. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
17. Rossiter H, Barresi C, Pammer J, Rendl M, Haigh J, Wagner EF, Tschachler E. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 2004;64:3508-3516.
18. Murphy WL, Peters MC, Kohn DH, Mooney DJ. Sustained release of vascular endothelial growth factor from mineralized poly(lactide- co-glycolide) scaffolds for tissue engineering. Biomaterials 2000;21:2521-2527.
19. Bouhadir KH, Mooney DJ. Promoting angiogenesis in engineered tissues. J Drug Target 2001;9:397-406.
20. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003;9(Suppl 1):S5-S15. (Pubitemid 37046603)
21. Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2- Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival. J Pathol 1999;188:369-377.
22. Marler JJ, Fishman SJ, Kilroy SM, Fang J, Upton J, Mulliken JB, Burrows PE, Zurakowski D, Folkman J, Moses MA. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics 2005;116:38-45.
23. Roth D, Piekarek M, Paulsson M, Christ H, Bloch W, Krieg T, Davidson JM, Eming SA. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am J Pathol 2006;168:670-684.
24. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999;1:1349-1365.
25. Kalluri R, Sukhatme VP. Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 2000;9:413-418.
26. Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun 1999;258:345-352.
27. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
28. Folkman J. Angiogenesis and angiogenesis inhibition: An overview. EXS 1997;79:1-8.
29. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000;18:1135-1149. (Pubitemid 30123793)
30. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
31. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 1997;3(12 Part 1):2485-2492.
32. Kajbafzadeh AM, Payabvash S, Salmasi AH, Sadeghi Z, Elmi A, Vejdani K, Tavangar SM, Tajik P, Mahjoub F. Time-dependent neovasculogenesis and regeneration of different bladder wall components in the bladder acellular matrix graft in rats. J Surg Res 2007;139:189-202.
33. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-1326. (Pubitemid 15000359)
34. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 2004;25:2789-2798.
35. Lindqvist U, Tolmachev V, Kairemo K, Astrom G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet 2002;41:603-613.
36. Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis. Cancer Res 2004;64:2941-2955.
37. Youssif M, Shiina H, Urakami S, Gleason C, Nunes L, Igawa M, Enokida H, Tanagho EA, Dahiya R. Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: Histologic and functional evaluation. Urology 2005;66:201-207.
38. Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 1996;156(2 Part 2):571-577.
39. Graham E, Chai TC. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 2006;7:440-446. (Pubitemid 44663234)
40. WuXR, Kong XP, Pellicer A, Kreibich G, Sun TT. Uroplakins in urothelial biology, function, and disease. Kidney Int 2009;75:1153-1165.
41. Nagele U, Maurer S, Feil G, Bock C, Krug J, Sievert KD, Stenzl A. In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings. Eur Urol 2008;54:1414-1422.
42. Riedel I, Czernobilsky B, Lifschitz-Mercer B, Roth LM, Wu XR, Sun TT, Moll R. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: Immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 2001;438:181-191.
43. Guan Y, Ou L, Hu G, Wang H, Xu Y, Chen J, Zhang J, Yu Y, Kong D. Tissue engineering of urethra using human vascular endothelial growth factor gene-modified bladder urothelial cells. Artif Organs 2008;32:91-99.
44. Kanematsu A, Yamamoto S, Iwai-Kanai E, Kanatani I, Imamura M, Adam RM, Tabata Y, Ogawa O. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 2005;166:565-573.
45. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001;7:382-383. (Pubitemid 32298513)